Reading time is 1 mins
.
.
NEW DRUG PROPOSAL FROM WHO AGAINST COVID-19
The World Health Organization has updated its covid-19 patient care guidelines, noting that for severe cases, drugs in the interleukin-6 receptor blockers group have saved lives.
Drugs in the interleukin-6 receptor blockers group saved lives in severe and critical Covid-19 patients when used in combination with corticosteroids, the WHO said. Who stated that the findings were the result of the widest analysis they had conducted on drugs and that data from more than 10 thousand patients participating in 27 clinical trials were taken into account. The WHO statement highlighted that they were the first drugs found to be effective against Covid-19 after corticosteroids were recommended in September 2020.
Covid-19 cases in a pass heavy, the immune system usually Covid-19 and patients I had seen overreacting to this situation, but interleukin-6 with tocilizumab and sarilumab blocking drugs and medications, the patient stated that by acting to suppress these extreme reactions are prevented. In critical cases, the drugs reduced the mortality rate by 13 percent, the WHO said, meaning there would be 15 fewer deaths for every thousand patients and 28 fewer deaths for every thousand critical patients.
.
.
.
.